Fluidigm Introduces Automated Advanta Solid Tumor NGS Library Prep Assay Using Microfluidics Technology

The first commercially available targeted NGS assay that enables simultaneous detection of somatic variants across 53 solid tumor genes using a highly efficient microfluidic library prep workflow SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today introduced the Advanta™ Solid Tumor NGS [...]

Fluidigm Introduces Advanta RNA Fusions NGS Library Prep Assay to Accelerate Translational and Clinical Cancer Research

Introducing the most comprehensive commercially available NGS assay for detecting gene fusions in cancer using an automated nanoscale library prep workflow SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today introduced the Advanta™ RNA Fusions NGS Library Prep Assay for detection of over 380 [...]

BioTek Announces New Wide Field of View Camera for Cytation™ 5

WINOOSKI VT, USA — BioTek Instruments announces a new wide field of view (FOV) camera option for their Cytation 5 Cell Imaging Multi-Mode Reader. The new wide FOV camera captures approximately four times the area compared to Cytation 5’s standard camera, allowing users to capture larger areas of interest with fewer images. The new camera increases [...]

Thermo Fisher Scientific and Scinogy Partner to Accelerate Cell and Gene Therapy Commercialization

New collaboration will enable scalable, cost-effective manufacturing processes CARLSBAD, Calif. -- Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Scinogy, specialists in closed, automated manufacturing systems for cell therapies, to develop and commercialize fit-for-purpose instrumentation and reagent systems aimed at improving productivity and scalability of cell and gene therapy manufacturing. [...]

MGI Sues Illumina for Patent Infringement in the United States

SAN JOSE, Calif. -- Complete Genomics Inc., a US subsidiary of MGI, has filed a patent infringement lawsuit against Illumina in US District Court for the District of Delaware. The lawsuit alleges that a number of genetic sequencers and related reagents from Illumina, including the NovaSeq 6000, NextSeq series, and MiniSeq, are infringing Complete Genomics' U.S. Patent No. 9,222,132 [...]

Announcing Benchling’s Partnership with iGEM: Empowering the Future of Synthetic Biology

At Benchling, we’ve been fortunate to support scientists doing some of the world’s most groundbreaking research—from designing CRISPR experiments and engineering CAR T cells to producing novel biomaterials. Over the years, more than 170,000 scientists have depended on Benchling to design DNA, collaborate on experiments, and manage complex research workflows. Many of these scientists are [...]

Pipette.com Will Be Adding Several New Tubes to Their Ecommerce Platform

SAN DIEGO - ​With a history of excellence and over 20 years of experience in calibrating pipettes, Pipette.com is the largest independent pipette calibration facility on the West Coast. Pipette.com is also a distributor of several manufacturers of tubes, plastics and lab equipment. Pipette.com just launched some additional tubes to its e-commerce platform. Pipette.com now offers centrifuge tubes manufactured with the highest [...]

University of California awarded CRISPR-Cas9-related patent for techniques that regulate gene expression

USPTO issues fifth U.S. CRISPR-Cas9-related patent to University of California, for new methods of modulating DNA transcription BERKELEY, Calif. -- The U.S. Patent and Trademark Office has issued a new patent to University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of modulating DNA transcription using the CRISPR-Cas9 system. U.S. Patent No. 10,301,651 covers techniques that enable [...]

Quantifying the value of genomics driven health care for children with rare diseases

VANCOUVER - Two million Canadian children are classified as having a rare disease. As these children and their families navigate these complex, life-threatening, or chronically debilitating conditions, their stories are often similar — they spend years experiencing a diagnostic odyssey that includes many hospital and clinic visits, tests and several misdiagnoses before a firm diagnosis is [...]

University of California awarded CRISPR-Cas9-related patent for techniques that regulate gene expression

USPTO issues fifth U.S. CRISPR-Cas9-related patent to University of California, for new methods of modulating DNA transcription BERKELEY, Calif. -- The U.S. Patent and Trademark Office has issued a new patent to University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of modulating DNA transcription using the CRISPR-Cas9 system. U.S. Patent No. 10,301,651 covers techniques that enable [...]

Access IBO on Knowledge Center